Pancreas-Kidney Transplantation and the Evolution of Pancreatic Autoantibodies

Transplantation Proceedings

Volumn 41, Issue 3, 2009, Pages 913-915

  Martins, L ^a   Malheiro, J ^a   Henriques, A C ^a   Dias, L ^a   Dores, J ^a   Oliveira, F ^a   Seca, R ^a   Almeida, R ^a   Sarmento, A M ^a   Cabrita, A ^a   Teixeira, M ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANCREAS ISLET CELL ANTIBODY; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 64349087254     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.068     Document Type: Article

References (14)

1. Castano L., and Eisenbarth G. Type 1 diabetes: a chronic autoimmune disease of human mouse and rat. Annu Rev Immunol 8 (1990) 647
2. Robertson P., Davis C., Larsen J., et al. Pancreas transplantation in type 1 diabetes. Position statement. Diabetes Care 27 suppl 1 (2004) S105
3. Petruzzo P., Andreelli F., McGregor B., et al. Evidence of type 1 diabetes following HLA-mismatched pancreas transplantation. Diabetes Metab 26 (2000) 215
4. Esmatjes E., Rodriguez-Villar C., Ricart M.J., et al. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation 66 (1998) 128
5. Tyden G., Reinholt F.P., Sundkivist G., et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic graft. N Engl J Med 335 (1996) 860
6. Sutherland D.E., Goetz F.C., Sibley R.K., et al. Recurrence of disease in pancreas transplants. Diabetes 38 suppl 1 (1989) 85
7. Braghi S., Bonifacio E., Secchi A., et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49 (2000) 218
8. Thivolet C., Abou-Amara S., Martin X., et al. Serological markers of recurrent beta cell destruction in diabetes patients undergoing pancreas transplantation. Transplantation 69 (2000) 99
9. Bosi E., Botazzo G.F., Secchi A., et al. Islet cell autoimmunity in type I diabetes patients after HLA-mismatched pancreas transplantation. Diabetes 38 suppl 1 (1989) 82
10. Clemens J., Bernhard H., Thomas D., et al. Islet cell autoantibodies and decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet after kidney transplantation. Transplantation 62 (1996) 424
11. Jaeger C., Brendel M., Hering B.J., et al. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in auto-antibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46 (1997) 1907
12. Mandrup-Poulson T., Nerup J., Stiller C.R., et al. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin treated patients. Lancet 2 (1985) 599
13. Dieterle C.D., Hierl F.X., Gutt B., et al. Insulin and islet autoantibodies after pancreas transplantation. Transpl Int 18 (2005) 1361
14. Repka J., Nicoluzzi J., Belila R., et al. Pancreatic islet cells antibodies in diabetic patients submitted to pancreas transplantation. Transplant Proc 38 (2006) 3031